Lockout at Pfizer Thane unit after labour unrest

The plant is the only manufacturing unit of Pfizer in India. It employs 212

BS Reporter New Delhi
Last Updated : Aug 02 2014 | 1:32 AM IST
Multinational drugmaker Pfizer has declared a lockout at its factory in Thane (Mumbai) after unrest among workers for the past few months.

The production had been stopped for at least four months, since there were “incidents of indiscipline”, making it difficult to continue operations peacefully, a Pfizer spokesperson said.

The plant was the only manufacturing unit of Pfizer in India. It employs 212.

Also Read

Pfizer said the lockout would not have any impact on its business operations, as it had a continuity plan.

The executive said it had made arrangements, including contract manufacturing of products and import arrangements, for the domestic market.

The management has not indicated any timeline for starting operations.

The company said, “We are not in a position to resume operations till we are assured by the workmen the safety of our colleagues would not be compromised in any manner and the workmen will not indulge in acts of indiscipline.”

Pfizer has annual turnover of Rs 948 crore in India. It sells leading brands such as Corex and Becosules in the domestic market. It is a major presenceyer in the anti-diabetes segment and is significantly present in anti-infectives, cardiovascular and respiratory drugs.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 02 2014 | 12:46 AM IST

Next Story